Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $439.16 | 6 | 94.8% |
| Education | $24.21 | 2 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $96.71 | 1 | $0 (2017) |
| Jazz Pharmaceuticals Inc. | $84.98 | 1 | $0 (2017) |
| Incyte Corporation | $83.21 | 1 | $0 (2017) |
| Cook Medical LLC | $80.69 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $73.83 | 1 | $0 (2017) |
| Genentech USA, Inc. | $19.74 | 1 | $0 (2017) |
| Seattle Genetics, Inc. | $12.29 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $80.69 | 1 | Cook Medical LLC ($80.69) |
| 2018 | $12.29 | 1 | Seattle Genetics, Inc. ($12.29) |
| 2017 | $358.47 | 5 | Ipsen Biopharmaceuticals, Inc ($96.71) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/21/2019 | Cook Medical LLC | Cook Medical Biliary (Device) | Food and Beverage | Cash or cash equivalent | $80.69 | General |
| Category: Endoscopy | ||||||
| 05/01/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 05/10/2017 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $73.83 | General |
| 04/27/2017 | Jazz Pharmaceuticals Inc. | Defitelio (Drug) | Food and Beverage | In-kind items and services | $84.98 | General |
| Category: Hematology | ||||||
| 03/15/2017 | Ipsen Biopharmaceuticals, Inc | Somatuline Depot 120mg-.5ml (Drug) | Food and Beverage | In-kind items and services | $96.71 | General |
| Category: Oncology/Endocrinology | ||||||
| 02/09/2017 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: BioOncology | ||||||
| 01/31/2017 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $83.21 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 903 | 1,487 | $314,475 | $120,115 |
| 2022 | 13 | 867 | 1,400 | $257,275 | $108,709 |
| 2021 | 12 | 820 | 1,412 | $237,308 | $103,630 |
| 2020 | 12 | 791 | 1,398 | $217,073 | $80,474 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 217 | 462 | $154,896 | $60,704 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 277 | $67,698 | $24,689 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 156 | $26,190 | $8,869 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $23,836 | $8,497 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $10,923 | $4,139 | 37.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 35 | $8,208 | $3,311 | 40.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 49 | 105 | $6,678 | $2,595 | 38.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 185 | 300 | $2,355 | $2,216 | 94.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $4,728 | $1,655 | 35.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $3,906 | $1,550 | 39.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 23 | $2,401 | $993.08 | 41.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,656 | $896.73 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 174 | 377 | $110,392 | $50,739 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 227 | $49,713 | $20,390 | 41.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 78 | 78 | $32,448 | $12,317 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 132 | $19,800 | $7,364 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $11,916 | $4,688 | 39.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 43 | $9,030 | $3,498 | 38.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 18 | $7,344 | $2,845 | 38.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 18 | $4,968 | $1,936 | 39.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 34 | 54 | $3,402 | $1,419 | 41.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 24 | $3,528 | $1,331 | 37.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 198 | 355 | $2,130 | $1,051 | 49.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 24 | $2,184 | $913.28 | 41.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 12 | 14 | $420.00 | $217.44 | 51.8% |
About Dr. James Boyer, M.D
Dr. James Boyer, M.D is a Hematology & Oncology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093769903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Boyer, M.D has received a total of $463.37 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 8 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($439.16).
As a Medicare-enrolled provider, Boyer has provided services to 3,381 Medicare beneficiaries, totaling 5,697 services with total Medicare billing of $412,928. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Charlottesville, VA
- Active Since 05/22/2006
- Last Updated 07/03/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1093769903
Products in Payments
- Somatuline Depot 120mg-.5ml (Drug) $96.71
- Defitelio (Drug) $84.98
- Cook Medical Biliary (Device) $80.69
- GAZYVA (Biological) $19.74
- ADCETRIS (Biological) $12.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Charlottesville
Michael Williams, M.d, M.D
Hematology & Oncology — Payments: $83,082
Craig Portell, M.d, M.D
Hematology & Oncology — Payments: $57,149
Kelly Davidson, M.d, M.D
Hematology & Oncology — Payments: $22,062
Krista Isaac, D.o, D.O
Hematology & Oncology — Payments: $9,826
Patrick Dillon, Md, MD
Hematology & Oncology — Payments: $2,776
Thomas Loughran, M.d, M.D
Hematology & Oncology — Payments: $2,149